
GC19196
Ibiglustat
Also known as [(3S)-1-azabicyclo[2.2.2]octan-3-yl] N-[2-[2-(4-fluorophenyl)-1,3-thiazol-4-yl]propan-2-yl]carbamate
Ibiglustat is an inhibitor of glucosylceramide synthase extracted from patent WO 2015089067 A1, compound example 64
ChemicalCAS1401090-53-6MW389.49FormulaC20H24FN3O2S
- CAS number
- 1401090-53-6
- Molecular weight
- 389.49
- Formula
- C20H24FN3O2S
- Solubility
- DMSO : ≥ 75 mg/mL (192·56 mM)
- InChIKey
- YFHRCLAKZBDRHN-MRXNPFEDSA-N
- Catalogue number
- GC19196
- Brand
- GLPBIO
Computed properties PubChem CID 60199242 · XLogP 3.5 · TPSA 82.7 Ų · H-bond donors 1
- XLogP
- 3.5
- TPSA
- 82.7 Ų
- H-bond donors
- 1
- H-bond acceptors
- 6
- Rotatable bonds
- 5
- Heavy atoms
- 27
SMILES CC(C)(C1=CSC(=N1)C2=CC=C(C=C2)F)NC(=O)O[C@@H]3CN4CCC3CC4
Computed descriptors from PubChem (CID 60199242), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il